Category Specific RSS

News

Alterity Therapeutics moves neuroprotective drug to Phase 2 trials

Seven to ten years. That’s how long someone diagnosed with multiple system atrophy (MSA) has to live from when symptoms…

4 years ago

Bubs to the rescue as special operation gets underway

Shareholders of Bubs Australia (ASX: BUB) reveled in every small cap investors' dream over the weekend - a direct shoutout…

4 years ago

Phase II begins for FirstWave’s cyber defence platform

Cyber crimes worldwide have been getting worse as the internet gets better, with reports from the national cybersecurity agency in…

4 years ago

Forget the details, Mighty Kingdom has just inked a deal with Google

Gaming company Mighty Kingdom (ASX: MKL) has partnered with some of the world’s most recognised brands like LEGO, Disney and…

4 years ago

Envirosuite’s machine learning wastewater tech ahead of schedule, accelerates growth

Environmental intelligence company Envirosuite (ASX: EVS) has provided a promising update on its newest product, EVS Water, which has picked…

4 years ago

Institutional investors back Apiam to accelerate growth amid regional boom

With it now abundantly clear that Australians who moved away from capital cities at the start of the pandemic have…

4 years ago

Now you see me, ClearVue and Nodis powering glass for US Air Force

ClearVue Technologies Ltd (ASX: CPV) and smart glass company Nodis Pte Ltd have signed a collaboration agreement to engineer an…

4 years ago

Cynata to tackle common transplant side effect with lead drug CYP-001

The first successful organ donation occurred in 1954 where a living donor gave a kidney to his identical twin. Since…

4 years ago

The key to happiness lies in your gut… No, really, just ask Microba

It’s no wonder that the health and wellness industry is worth over $4 trillion when you look at my bank…

4 years ago